Skip to main content

Advertisement

Table 1 Patients demographics

From: Efficacy of 4′-[methyl-11C] thiothymidine PET/CT before and after neoadjuvant therapy for predicting therapeutic responses in patients with esophageal cancer: a pilot study

Demographics Number
Patients 26
Sex, male 23
Mean age years (standard deviation) 66.4 (9.7)
Location
 Upper 7
 Middle 14
 Lower 5
Clinical T-stage
 cT2 2
 cT3 13
 cT4 11
Clinical N-stage
 cN0 6
 cN1 6
 cN2 13
 cN3 1
Neoadjuvant therapy
 Chemotherapy 14
 Chemoradiotherapy 12
Tumor marker
 SCC (ng/mL) [median, (range)] 2.2 (0.6, 8.1)
 CEA (ng/mL) [median, (range)] 2.2 (0.2, 8.6)